Mark Thompson Say what you will, I still trust him to drive this company to a better future. Slowly starting to emerge as a clearly different company who focuses on the products not the companies they acquire. I love that MT maintains his commitment and that he sticks with his vision for CXR. He obviously doesn't want to be painted with the same brush as VRX and I'm sure he'll be doing everything in 2016 not to get any bad press. Yes, that means not raising drug prices abnormally which he never did anyway ( after all the bad press, the data is pretty clear on the matter).
Long and strong. 2016 will be a good year for us.